Skin autofluorescence: A tool to identify type 2 diabetic patients at risk for developing microvascular complications

Diabetes Care

Volumn 31, Issue 3, 2008, Pages 517-521

  Gerrits, Esther G ^a   Lutgers, Helen L ^b   Kleefstra, Nanne ^a,c   Graaff, Reindert ^b,e   Groenier, Klaas H ^b   Smit, Andries J ^d,e   Gans, Rijk O ^b,d   Bilo, Henk J ^a,b,d  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LANGERHANS MEDICAL RESEARCH GROUP   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e DiagnOptics BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; ADVANCED GLYCATION END PRODUCT;

AGED; ARTICLE; AUTOFLUORESCENCE; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; SKIN AUTOFLUORESCENCE; SKIN EXAMINATION; SMOKING; CARDIOVASCULAR DISEASE; CHEMISTRY; DIABETES MELLITUS; FLUORESCENCE; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SKIN; SPECTROFLUOROMETRY;

AGED; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SKIN; SPECTROMETRY, FLUORESCENCE;

EID: 44449155477     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-1755     Document Type: Article

References (20)

1. Smith U, Laakso M, Eliasson B, Wesslau C, Borén J, Wiklund O, Attvall S: Pathogenesis and treatment of diabetic vascular disease: illustrated by two cases. J Int Med 260:409-420, 2006
2. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625, 2005
3. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
4. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner R, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000
5. Klein R, Klein BE, Moss SE: Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 124:90-96, 1996
6. Pirart J: Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (part 1). Diabetes Care 1:168-188, 1978
7. Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S, the DCCT Skin Collagen Ancillary Study Group: Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus A1C as markers of diabetic complications. Diabetes 48:870-880, 1999
8. Genuth S, Sun S, Cleary PA, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM, the DCCT Skin Collagen Ancillary Study Group: Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications participants with type 1 diabetes. Diabetes 54:3103-3111, 2005
9. Meerwaldt R, Graaff R, Oomen PHN, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans ROB, Smit AJ: Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 47:1324-1330, 2004
10. Meerwaldt R, HartogJWL, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans ROB, Smit AJ: Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 16:3687-3693, 2005
11. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, Smit AJ: Skin autofluorescence as a non-invasive marker of vascular damage in patients with type 2 diabetes mellitus. Diabetes Care 29:2654-2659, 2006
12. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans ROB, Smit AJ: Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 30:107-112, 2007
13. Fitzpatrick TB: Soleil et peau. J Med Esthet 2:33-34, 1975 [article in French]
14. Fitzpatrick TB: The validity and practicability of sun-reactive skin types I through VI. Arch Dermatol 124:869-871, 1988
15. Kawada A: Risk and preventive factors for skin phototype. J Dermatol Sci. 23 (Suppl. 1):S27-S29, 2000
16. Diabetes dictionary [article online]. Alexandria, VA, American Diabetes Association. Available from http://www.diabetes.org/diabetesdictionary.jsp. Accessed 1 February 2008
17. Rutten GEHM, De Grauw WJC, Nijpels G, Goudswaard AN, Uitewaal PJM, Van der Does FEE, Heine RJ, Van Ballegooie E, Verduijn MM, Bouma M: Diabetes mellitus type 2. Huisarts en Wetenschap 49:137-152,2006
18. Valk GD, de Sonnaville JJ, van Houtum WH, Heine RJ, van Eijk JT, Bouter LM, Bertelsmann FW: The assessment of diabetic polyneuropathy in daily clinical practice: reproducibility and validity of Semmes-Weinstein monofilaments examination and clinical neurological examination. Muscle Nerve 20:116-118, 1997
19. Bilo HJG, de Grauw WJC, Vervoort G, Blok G, Gans ROB, Houdijk ECAM, Navis GJ, Slingerland RJ, van der Zee M: NIVCBO: [NIV-CBO Dutch national diabetic nephropathy guideline]. ISBN-IO: 90-8523-138-8, 2006 [article in Dutch]
20. Aiello LP, Wong JS: Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int 58 (Suppl. 7):S113-S119, 20003